Big Pharma Compliance Policies Can Add Trouble For Biotech Partners – Panel
Executive Summary
Biotechs should be wary of entering into copromotion partnerships with larger pharmaceutical firms that have onerous compliance policies, panelists suggested during a Feb. 12 roundtable at the Biotechnology Industry Organization CEO & Investor Conference in New York